AnalystsWilliam TannerWilliam Tanner's Stock Forecasts
AnalystsWilliam Tanner
Sectors:
Analyst Ranking
Top 26%
#1234 out of 4873 analysts
Average Return
+36.39%
Win Rate
44%4 out of 9
Risk vs Reward
Poor
Good
William Tanner's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arena Pharmaceuticals IncARNA | +292.62% | $12.60 | $49.47 | 2017-06-14 - 2018-06-15 | Strong Buy |
Xencor IncXNCR | +102.39% | $20.50 | $41.49 | 2017-11-28 - 2018-11-29 | Strong Buy |
Cymabay Therapeutics IncCBAY | +56.96% | $7.69 | $12.07 | 2017-09-19 - 2018-09-20 | Strong Buy |
Aimmune Therapeutics IncAIMT | +19.82% | $23.86 | $28.59 | 2018-12-02 - 2019-12-03 | Strong Buy |
William Tanner Analyst Color
Get additional color on William Tanner's coverage of popular stocks
William Tanner's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Prothena Corp Public Ltd CoPRTA | 3 | Strong Buy | N/A | N/A | Assumes | 6 years ago |
Aimmune Therapeutics IncAIMT | 2 | Strong Buy | $64.00 | N/A | Assumes | 6 years ago |
Therapeuticsmd IncTXMD | 1 | Strong Buy | $1,350.00 | N/A | Maintains | 7 years ago |
Amag Pharmaceuticals IncAMAG | 1 | Hold | $18.00 | N/A | Maintains | 7 years ago |
Xencor IncXNCR | 1 | Strong Buy | $33.00 | N/A | Initiates Coverage On | 7 years ago |
Acorda Therapeutics IncACORQ | 2 | Hold | $1,920.00 | N/A | Maintains | 7 years ago |
Cymabay Therapeutics IncCBAY | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 8 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $4.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.